Beta Drugs Share Price
Live Beta Drugs Share Price Chart
Beta Drugs Performance
Days Range
| Previous Close | ₹1,838.50 |
|---|---|
| Open | ₹1,874.90 |
| Volume | 11,610 |
| Day's Range | ₹1,810.50 - ₹1,890.70 |
|---|---|
| 52W Range | ₹990.10 - ₹2,807.90 |
| Market Cap | ₹2,021.18 Cr |
Beta Drugs Fundamentals
| ROCE(TTM) | 16.78 |
|---|---|
| P/E Ratio (TTM) | 37.89 |
| P/B Ratio | 4.62 |
| Industry P/E | 40.65 |
| Debt to Equity | 0.11 |
| ROE | 11.86 |
| EPS (TTM) | 46.68 |
| Dividend Yield | N/A |
| Book Value | 393.57 |
| Face Value | 10 |
| ROCE(TTM) | 16.78 |
|---|---|
| P/E Ratio (TTM) | 37.89 |
| P/B Ratio | 4.62 |
| Industry P/E | 40.65 |
| Debt to Equity | 0.11 |
| ROE | 11.86 |
|---|---|
| EPS (TTM) | 46.68 |
| Dividend Yield | N/A |
| Book Value | 393.57 |
| Face Value | 10 |
Beta Drugs Financials
| Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|
| Net Sales | 87.27 | 93.96 | 125.55 | 137.49 |
| Expenses | 74.67 | 81.08 | 102.53 | 111.82 |
| Profit before tax | 10.47 | 11.83 | 22.04 | 25.78 |
| Operating Profit | 8.52 | 9.05 | 16.49 | 19.28 |
| Net Profit | 8.52 | 9.05 | 16.49 | 19.28 |
| EPS in Rs | 8.40 | 8.93 | 14.78 | 16.59 |
Beta Drugs Shareholding Pattern
Promoters
58.91%
Retail And Others
33.27%
Foreign Institutional Investors
1.37%
Domestic Institutional Investors
6.45%
About Beta Drugs
Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017
Beta Drugs is a part of Adley Group. The company is primarily engaged in the manufacturing of oncology products. The products ranges from anti-cancer tablets, capsules, injections and lyophilized injections.
The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. It setup the first Oncology Unit in Adley Formulations Pvt Ltd. in 2008. It set up a new 'state of the art' manufacturing facility for oncology formulations in 2014; developed in-house Albumin bound Paclitaxel in 2015; started in-house API Plant - Adley Labs in 2017.
In October, 2017, the Company came up with a Public Issue of 22,96,000 Equity Shares by raising equity capital aggregating Rs 19.5 Crores.
The Company set up an Oncology Plant in Uzbekistan in 2018. In 2020, the Company launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB; launched 1st Indian Brand of Dasatinib, BEEDAN. In 2025, the Company launched 1st Indian brand of Sunitinib, ADSUNIB.
The Company acquired a 66.09% stake in Nivian Lifescience Private Limited through preferential allotment in FY 2025-26.
Parent Organisation
Indian Private
Managing Director
Rahul Batra
Founded
2005
NSE Symbol
BETA
Top Mutual Funds Invested in Beta Drugs Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,880.0 -5.00 (-0.27%) | ₹4,51,290.91 | 1,583.7 - 2,046.9![]() |
| Divis Laboratories Ltd | 11,442.0 -43.00 (-0.37%) | ₹3,05,014.11 | 5,647.5 - 11,824.0![]() |
| Torrent Pharmaceuticals Ltd | 4,670.0 -57.20 (-1.21%) | ₹1,77,333.20 | 3,672.3 - 5,250.0![]() |
| Laurus Labs Ltd | 2,424.0 24.00 (1.00%) | ₹1,30,755.56 | 917.95 - 2,488.0![]() |
| Zydus Lifesciences Ltd | 1,189.9 -16.10 (-1.33%) | ₹1,18,802.71 | 835.5 - 1,266.6![]() |
| Dr Reddys Laboratories Ltd | 1,380.0 -6.60 (-0.48%) | ₹1,15,016.89 | 1,101.0 - 1,414.9![]() |
Popular Stocks
Beta Drugs Ltd FAQs
Can I buy Beta Drugs Ltd (BETA) from Angel One?
Yes, You can buy Beta Drugs Ltd (BETA) shares by opening a Demat account with Angel One.
How do I buy Beta Drugs Ltd (BETA) from Angel One?
Beta Drugs Ltd (BETA) share can be bought through the following modes:
1. Direct investment: You can buy Beta Drugs Ltd (BETA) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Beta Drugs Ltd (BETA) shares.
1. Direct investment: You can buy Beta Drugs Ltd (BETA) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Beta Drugs Ltd (BETA) shares.








